Live Breaking News & Updates on Cancer Therapies Group

Stay updated with breaking news from Cancer therapies group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

First MYC inhibitor to demonstrate safety and anti-tumor activity in a phase I first-in-human clinical trial

First MYC inhibitor to demonstrate safety and anti-tumor activity in a phase I first-in-human clinical trial
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Laura Soucek , Elena Garralda , Raquel Perez Lopez , Emiliano Calvo , Radiomics Group , Early Clinical Drug Development Group , Experimental Therapeutics Program , Models Of Cancer Therapies Group , Catalan Institute Of Research , University Hospitals , Research Unit For Molecular Therapy Of Cancer , Research Professor , Therapeutics Program , Cancer Therapies Group , Catalan Institute , Advanced Studie , Marie Eve Beaulieu , Chief Scientific , Nature Medicine , Molecular Therapy , Medical Oncologist ,

Promising Preclinical Results for MYC Inhibition in Melanoma

Promising Preclinical Results for MYC Inhibition in Melanoma
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Israel General , Marianof Zacar , Laura Soucek , Models Of Cancer Therapies Group , Genes Development , Spanish Ministry Of Economy , Translational Research Program , Hebron Institute Of Oncology , European Research Council , Spanish Ministry Of Science , Catalan Institute Of Research , Research Professor , Hebron Institute , Principal Investigator , Cancer Therapies , Catalan Institute , Advanced Studie , Research Associate , Cancer Therapies Group , Spanish Ministry , Generalitat De Catalunya , European Research ,

Omomyc Mini-Protein Maintains Integrity in Tumor for 72 Hours

Omomyc Mini-Protein Maintains Integrity in Tumor for 72 Hours
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Israel General , Comunidad Autonoma De Cataluna , Laura Soucek , European Union Horizon , Catalan Institute Of Research , Research Professor , Hebron Institute Of Oncology , Spanish Ministry Of Science , Models Of Cancer Therapies Group , Translational Research , Cancer Therapies Group , Hebron Institute , Catalan Institute , Advanced Studies , Chief Executive Officer , Marie Eve Beaulieu , Chief Scientific Officer , Principal Investigator , Cancer Therapies , European Union , Spanish Ministry ,

Omomyc as the first MYC-targeted therapy to successfully complete a phase I clinical trial

Omomyc as the first MYC-targeted therapy to successfully complete a phase I clinical trial
sciencex.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencex.com Daily Mail and Mail on Sunday newspapers.

Newcastle Upon Tyne , United Kingdom , Israel General , Laura Soucek , Elena Garralda , Ruth Plummer , Research Professor , Translational Research Program , Catalan Institute Of Research , Research Unit For Molecular Therapy Of Cancer , Hebron Institute Of Oncology , Northern Centre For Cancer Care , Scientific Committee , Models Of Cancer Therapies Group , Early Clinical Drug Development Group , Hebron Institute , Principal Investigator , Cancer Therapies Group , Catalan Institute , Advanced Studie , Molecular Therapy , Clinical Drug Development Group , Northern Centre , Cancer Care , Chief Executive Director ,

MYC Inhibition Found to Be Anti-Metastatic in Breast Cancer

In a new study, researchers demonstrate how MYC inhibition by Omomyc dramatically reduces both primary and metastatic growth in breast cancer. ....

Israel General , Laura Soucek , Hebron Institute Of Oncology , Cancer Research Communications , Models Of Cancer Therapies Group Vall , Hebron Institute , Cancer Therapies Group , Hebron Barcelona Hospital Campus , Halts Metastatic Breast Cancer Progression , Blocking Growth , Daniel Mass ,